HR Execs on the Move

NuVasive

www.nuvasive.com

 
NuVasive® is an innovative medical device company focused on developing minimally disruptive surgical products and procedures for the spine. Our mission is to improve the lives of patients who suffer from debilitating back, neck, or leg pain by creating cutting-edge products and procedures that revolutionize spine surgery through focusing on Speed of Innovation®, Absolute Responsiveness®, and Superior Clinical Results. Through innovative technological advancements, NuVasive has successfully progressed major spine surgery to where many patients have experienced extraordinary results—they are often walking the same day of surgery, experiencing less blood loss, spending less time in the hospital, and going back to work ...
  • Number of Employees: 250-1000
  • Annual Revenue: $100-250 Million
  • www.nuvasive.com
  • 7475 Lusk Boulevard
    San Diego, CA USA 92121
  • Phone: 858.909.1800

Executives

Name Title Contact Details
Michael Kannisto
Global Head of Talent Acquisition Profile
Wendy Harrison
Human Resources Director Profile
Mike Moeller
Sr VP of R&D and Operations Profile
Rob German
VP, Global Implant Systems R&D Profile
Justin Smith
Senior Director, Surgical Intelligence R&D Profile

Similar Companies

Life Support Services Inc

Life Support Services Inc is a Ann Arbor, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Advanced Diabetes Supply

Advanced Diabetes Supply provides diabetes testing supplies to people nationwide. Our highly trained staff and state of the art technology ensures fast and convenient home delivery anywhere in the country.

Canadian Agency for Drugs and Technologies

Canadian Agency for Drugs & Technologies is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

HealthCarts.com

HealthCarts.com is a Plymouth, MI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Cytori

Cytori Therapeutics is dedicated to developing and delivering innovative cell-based therapies to improve the quality and length of life. We are a global, public company engaged in the development and commercialization of stem and regenerative cell therapies for the treatment of cardiovascular disease, reconstructive surgery and other serious, chronic, and life threatening conditions.